Related references
Note: Only part of the references are listed.Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Peter Serfozo et al.
HYPERTENSION (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System
Jan Wysocki et al.
BIOMOLECULES (2019)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
Yumiko Imai et al.
CIRCULATION JOURNAL (2010)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
